Skip to main content
Top
Published in: International Urology and Nephrology 2/2017

01-02-2017 | Nephrology - Original Paper

Hypoalbuminemia: a risk factor for acute kidney injury development and progression to chronic kidney disease in critically ill patients

Authors: Min Shao, Shengyu Wang, Praveen Kolumam Parameswaran

Published in: International Urology and Nephrology | Issue 2/2017

Login to get access

Abstract

Purpose

The increased likelihood of poor outcomes in critically ill patients with hypoalbuminemia is well recognized. However, hypoalbuminemia remains poorly defined as an independent predictor of acute kidney injury (AKI) and stage 4 chronic kidney diseases (CKD4). The aim of this study was to assess the role of hypoalbuminemia as an independent risk factor for AKI and CKD4 in critically ill patients.

Design

A retrospective cohort study.

Setting

General intensive care unit (ICU) at Anhui Provincial Hospital, PR China.

Intervention

None.

Measurements and main results

We screened patients admitted to the ICU at Anhui Provincial Hospital between January 1, 2008, and October 31, 2011, and included those aged >18 years with available records of serum albumin (SA), baseline serum creatinine, and outcome data. The exclusion criteria were: (1) patients with known AKI and CKD stage 4, 5 before ICU admission; (2) patients lost to follow-up; and (3) patients without research authorization. A total of 588 patients with available data were enrolled in the study, and 62 patients with preexisting CKD stage 4 and CKD stage 5 and 115 with preexisting AKI were excluded. Thirty patients were lost to follow-up. Ultimately, 381 patients were analyzed, 233 (61.2%) of whom developed AKI. Patients with low SA were significantly more likely than those with normal SA (p = 0.0003) to develop AKI, and to progress from AKI to CKD4 (p = 0.0229). More patients in the AKI group than in the non-AKI group had risk factors such as hypotension, mechanical ventilation (MV), proteinuria, sepsis, nephrotoxin exposure, and high-risk surgery (p < 0.01). The difference in duration of MV, ICU days, ICU mortality, hospital days, and hospital mortality between the AKI and non-AKI groups was also significant (p < 0.01). Logistic regression showed that hypoalbuminemia was significantly associated with AKI and CKD4 [odds ratio (OR) 1.810, 95% confidence interval (CI) 1.102–2.992, and OR 2.494, 95% CI 1.231–5.295, respectively]. After 4 years of follow-up, Kaplan–Meier analysis showed that survival in hypoalbuminemia patients was significantly shorter than in patients with normal SA (p = 0.0393). In the Cox proportional hazard model, hypoalbuminemia was an independent predictor of long-term mortality (hazard ratio 1.5, 95% CI 1.042–2.183, p = 0.0291).

Conclusion

Hypoalbuminemia in critically ill patients is independently associated with an increased risk of development of AKI and AKI progressing to CKD4.
Appendix
Available only for authorised users
Literature
1.
go back to reference Uchino S, Kellum JA, Bellomo R et al (2005) Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294(7):813–818CrossRefPubMed Uchino S, Kellum JA, Bellomo R et al (2005) Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294(7):813–818CrossRefPubMed
2.
go back to reference Waikar SS, Liu KD, Chertow GM (2008) Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol 3(3):844–861CrossRefPubMed Waikar SS, Liu KD, Chertow GM (2008) Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol 3(3):844–861CrossRefPubMed
4.
go back to reference Ali T, Khan I, Simpson W et al (2007) Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol 18(4):1292–1298CrossRefPubMed Ali T, Khan I, Simpson W et al (2007) Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol 18(4):1292–1298CrossRefPubMed
5.
go back to reference Joannidis M, Metnitz B, Bauer P et al (2009) Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med 35(10):1692–1702CrossRefPubMed Joannidis M, Metnitz B, Bauer P et al (2009) Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med 35(10):1692–1702CrossRefPubMed
6.
go back to reference Metnitz PG, Krenn CG, Steltzer H et al (2002) Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 30(9):2051–2058CrossRefPubMed Metnitz PG, Krenn CG, Steltzer H et al (2002) Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 30(9):2051–2058CrossRefPubMed
7.
go back to reference Joannidis M, Metnitz PG (2005) Epidemiology and natural history of acute renal failure in the ICU. Crit Care Clin 21(2):239–249CrossRefPubMed Joannidis M, Metnitz PG (2005) Epidemiology and natural history of acute renal failure in the ICU. Crit Care Clin 21(2):239–249CrossRefPubMed
9.
go back to reference Herrmann FR, Safran C, Levkoff SE et al (1992) Serum albumin level on admission as a predictor of death, length of stay, and readmission. Arch Intern Med 152(1):125–130CrossRefPubMed Herrmann FR, Safran C, Levkoff SE et al (1992) Serum albumin level on admission as a predictor of death, length of stay, and readmission. Arch Intern Med 152(1):125–130CrossRefPubMed
10.
go back to reference McCluskey A, Thomas AN, Bowles BJ et al (1996) The prognostic value of serial measurements of serum albumin concentration in patients admitted to an intensive care unit. Anaesthesia 51(8):724–727CrossRefPubMed McCluskey A, Thomas AN, Bowles BJ et al (1996) The prognostic value of serial measurements of serum albumin concentration in patients admitted to an intensive care unit. Anaesthesia 51(8):724–727CrossRefPubMed
11.
12.
go back to reference Amdur RL, Chawla LS, Amodeo S et al (2009) Outcomes following diagnosis of acute renal failure in U.S. veterans: focus on acute tubular necrosis. Kidney Int 76(10):1089–1097CrossRefPubMed Amdur RL, Chawla LS, Amodeo S et al (2009) Outcomes following diagnosis of acute renal failure in U.S. veterans: focus on acute tubular necrosis. Kidney Int 76(10):1089–1097CrossRefPubMed
13.
go back to reference Wald R, Quinn RR, Luo J et al (2009) Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 302(11):1179–1185CrossRefPubMed Wald R, Quinn RR, Luo J et al (2009) Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 302(11):1179–1185CrossRefPubMed
14.
go back to reference Mehta RL, Kellum JA, Shah SV et al (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11(2):R31CrossRefPubMedPubMedCentral Mehta RL, Kellum JA, Shah SV et al (2007) Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11(2):R31CrossRefPubMedPubMedCentral
15.
go back to reference Kasiske BL, Wheeler DC (2014) Kidney disease: improving global outcomes—an update. Nephrol Dial Transpl 29(4):763–769CrossRef Kasiske BL, Wheeler DC (2014) Kidney disease: improving global outcomes—an update. Nephrol Dial Transpl 29(4):763–769CrossRef
16.
go back to reference Wiedermann CJ, Wiedermann W, Joannidis M (2010) Hypoalbuminemia and acute kidney injury: a meta-analysis of observational clinical studies. Intensive Care Med 36(10):1657–1665CrossRefPubMed Wiedermann CJ, Wiedermann W, Joannidis M (2010) Hypoalbuminemia and acute kidney injury: a meta-analysis of observational clinical studies. Intensive Care Med 36(10):1657–1665CrossRefPubMed
17.
go back to reference Kheterpal S, Tremper KK, Heung M et al (2009) Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Anesthesiology 110(3):505–515CrossRefPubMed Kheterpal S, Tremper KK, Heung M et al (2009) Development and validation of an acute kidney injury risk index for patients undergoing general surgery: results from a national data set. Anesthesiology 110(3):505–515CrossRefPubMed
18.
go back to reference Matheny ME, Miller RA, Ikizler TA et al (2010) Development of inpatient risk stratification models of acute kidney injury for use in electronic health records. Med Decis Making 30(6):639–650CrossRefPubMedPubMedCentral Matheny ME, Miller RA, Ikizler TA et al (2010) Development of inpatient risk stratification models of acute kidney injury for use in electronic health records. Med Decis Making 30(6):639–650CrossRefPubMedPubMedCentral
19.
go back to reference Basu RK, Zappitelli M, Brunner L et al (2014) Derivation and validation of the renal angina index to improve the prediction of acute kidney injury in critically ill children. Kidney Int 85(3):659–667CrossRefPubMed Basu RK, Zappitelli M, Brunner L et al (2014) Derivation and validation of the renal angina index to improve the prediction of acute kidney injury in critically ill children. Kidney Int 85(3):659–667CrossRefPubMed
20.
go back to reference Cruz DN, Ferrer-Nadal A, Piccinni P et al (2014) Utilization of small changes in serum creatinine with clinical risk factors to assess the risk of AKI in critically lll adults. Clin J Am Soc Nephrol 9(4):663–672CrossRefPubMedPubMedCentral Cruz DN, Ferrer-Nadal A, Piccinni P et al (2014) Utilization of small changes in serum creatinine with clinical risk factors to assess the risk of AKI in critically lll adults. Clin J Am Soc Nephrol 9(4):663–672CrossRefPubMedPubMedCentral
21.
go back to reference Contreras AM, Ramirez M, Cueva L et al (1994) Low serum albumin and the increased risk of amikacin nephrotoxicity. Rev Invest Clin 46(1):37–43PubMed Contreras AM, Ramirez M, Cueva L et al (1994) Low serum albumin and the increased risk of amikacin nephrotoxicity. Rev Invest Clin 46(1):37–43PubMed
22.
go back to reference Levine JS, Koh JS, Triaca V et al (1997) Lysophosphatidic acid: a novel growth and survival factor for renal proximal tubular cells. Am J Physiol 273(4 Pt 2):F575–F585PubMed Levine JS, Koh JS, Triaca V et al (1997) Lysophosphatidic acid: a novel growth and survival factor for renal proximal tubular cells. Am J Physiol 273(4 Pt 2):F575–F585PubMed
23.
go back to reference Iglesias J, Abernethy VE, Wang Z et al (1999) Albumin is a major serum survival factor for renal tubular cells and macrophages through scavenging of ROS. Am J Physiol 277(5 Pt 2):F711–F722PubMed Iglesias J, Abernethy VE, Wang Z et al (1999) Albumin is a major serum survival factor for renal tubular cells and macrophages through scavenging of ROS. Am J Physiol 277(5 Pt 2):F711–F722PubMed
24.
go back to reference Kaufmann MA, Castelli I, Pargger H et al (1995) Nitric oxide dose-response study in the isolated perfused rat kidney after inhibition of endothelium-derived relaxing factor synthesis: the role of serum albumin. J Pharmacol Exp Ther 273(2):855–862PubMed Kaufmann MA, Castelli I, Pargger H et al (1995) Nitric oxide dose-response study in the isolated perfused rat kidney after inhibition of endothelium-derived relaxing factor synthesis: the role of serum albumin. J Pharmacol Exp Ther 273(2):855–862PubMed
25.
go back to reference Lee YJ, Han HJ (2008) Albumin-stimulated DNA synthesis is mediated by Ca2+/PKC as well as EGF receptor-dependent p44/42 MAPK and NF-kappaB signal pathways in renal proximal tubule cells. Am J Physiol Renal Physiol 294(3):F534–F541CrossRefPubMed Lee YJ, Han HJ (2008) Albumin-stimulated DNA synthesis is mediated by Ca2+/PKC as well as EGF receptor-dependent p44/42 MAPK and NF-kappaB signal pathways in renal proximal tubule cells. Am J Physiol Renal Physiol 294(3):F534–F541CrossRefPubMed
26.
go back to reference Dixon R, Brunskill NJ (1999) Activation of mitogenic pathways by albumin in kidney proximal tubule epithelial cells: implications for the pathophysiology of proteinuric states. J Am Soc Nephrol 10(7):1487–1497PubMed Dixon R, Brunskill NJ (1999) Activation of mitogenic pathways by albumin in kidney proximal tubule epithelial cells: implications for the pathophysiology of proteinuric states. J Am Soc Nephrol 10(7):1487–1497PubMed
27.
go back to reference Gariballa SE, Parker SG, Taub N et al (1998) Influence of nutritional status on clinical outcome after acute stroke. Am J Clin Nutr 68(2):275–281PubMed Gariballa SE, Parker SG, Taub N et al (1998) Influence of nutritional status on clinical outcome after acute stroke. Am J Clin Nutr 68(2):275–281PubMed
28.
go back to reference Knaus WA, Wagner DP, Draper EA et al (1991) The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 100(6):1619–1636CrossRefPubMed Knaus WA, Wagner DP, Draper EA et al (1991) The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 100(6):1619–1636CrossRefPubMed
29.
go back to reference Caironi P, Tognoni G, Masson S et al (2014) Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 370(15):1412–1421CrossRefPubMed Caironi P, Tognoni G, Masson S et al (2014) Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 370(15):1412–1421CrossRefPubMed
Metadata
Title
Hypoalbuminemia: a risk factor for acute kidney injury development and progression to chronic kidney disease in critically ill patients
Authors
Min Shao
Shengyu Wang
Praveen Kolumam Parameswaran
Publication date
01-02-2017
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 2/2017
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1453-2

Other articles of this Issue 2/2017

International Urology and Nephrology 2/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.